D-0535-2022 Class II Terminated

Recalled by ULTRAtab Laboratories, Inc. — Highland, NY

FDA drug recall D-0535-2022 was initiated by ULTRAtab Laboratories, Inc. on Jan 26, 2022 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jan 7, 2025). Affected quantity: 6,215,512 tablets.

Recall Details

Product Type
Drugs
Report Date
Feb 16, 2022
Initiation Date
Jan 26, 2022
Termination Date
Jan 7, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,215,512 tablets

Product Description

Extra-Strength Unaspirin caplet (Acetaminophen 500 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-207-00

Reason for Recall

CGMP Deviations

Distribution Pattern

Bulk product was distributed to 3 distributors who may have distributed finished product.

Code Information

Product Codes: L207L Bulk Lots: 18K111, 19E104, 19F050

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0535-2022
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.